SCHEMBL29924941

SCHEMBL29924941

Clc1ccccc1-c1cn2c(n1)sc1cc(Br)ccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.47
CA1 P00915 3/20 0.47
CA2 P00918 3/20 0.47
CA9 Q16790 3/20 0.47
MAPT P10636 6/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
ATM Q13315 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
F2RL3 Q96RI0 1/20 0.45
THRB P10828 2/20 0.45
MET P08581 1/20 0.39
APP P05067 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
RXFP1 Q9HBX9 1/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30537875 0.85 MAPT (0.49) CA12CA1CA2CA9MAPT
SCHEMBL30537900 0.85 CA12 (0.47) CA12CA1CA2CA9MAPT
SCHEMBL9569396 0.84 THRB (0.56) CA12CA1CA2CA9MAPT
SCHEMBL20893101 0.82 TP53 (0.67) MAPTRAB9ASMN1; SMN2LMNATP53
SCHEMBL24105970 0.80 CA12 (0.52) CA12CA1CA2CA9MAPT
SCHEMBL30537918 0.80 MAPT (0.52) CA12CA1CA2CA9MAPT
SCHEMBL29924606 0.80 MAPT (0.51) CA12CA1CA2CA9MAPT
SCHEMBL24619365 0.75 MAPT (0.55) MAPTRAB9ASMN1; SMN2LMNATP53
SCHEMBL29925183 0.75 MAPT (0.55) MAPTRAB9ASMN1; SMN2LMNATP53
SCHEMBL30537891 0.75 MAPT (0.52) CA12CA1CA2CA9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4274569-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER Anima Biotech Inc. (US) 2023-11-15 EP disclosed
CN-116635028-A Modulators of c-MYC mRNA translation and their use in the treatment of cancer 艾尼莫生物科技公司 2023-08-22 CN disclosed
WO-2022150316-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC. (US) 2022-07-14 WO disclosed